Dr. Michael Spellberg is a registered patent attorney practicing in the area of biotechnology. His practice includes patent preparation and prosecution, global IP portfolio management, freedom-to-operate analyses, and due diligence and opinion work. Dr. Spellberg’s practice covers all areas of biotechnology, including biologic therapies, research tools, screening assays, bioprocessing and purification, with a particular focus on oligonucleotide therapeutics, mRNA technology, antibody therapeutics, and cell therapies.
Dr. Spellberg’s research background is in cancer immunology and molecular biology. Prior to joining the firm, Dr. Spellberg served as a postdoctoral research fellow for Dr. Carl Novina at the Dana Farber Cancer Institute, where he used cutting-edge CRISPR technology in the development of tools to epigenetically modify cancer cells and immune cells as a novel therapy.